SeroSelectTB
Project
|Last update
SeroSelectTB is a multinational project coordinated by the Norwegian Institute of Public Health.
Summary
The performance of a new triage test for active tuberculosis, SeroSelectTB, will be qualified in multi-centre randomised controlled trials at health-posts in South Africa, Tanzania and Ethiopia. Cost effectiveness evaluations will be conducted to support a value proposition to stakeholders and regulatory authorities, and to support commercialization requirements. Consenting adults will provide blood and saliva samples for screening by SeroSelectTB, and sputum collected for routine TB diagnosis by the health services. Clinical and sociodemographic information will be collected. A reliable rapid test will make it possible to identify and selectively treat those with active TB at the local healthcare level. The expected impact includes accurate same-day diagnosis of patients with active TB, reduction of diagnostic delay and TB transmission, and diagnostic cost-savings for patients and healthcare systems in high burden countries.
SeroSelectTB is a multinational project coordinated by the Norwegian Institute of Public Health (Oslo, Norway). Partners include Stellenbosch University and Lateral Flow Laboratories (South Africa), Kilimanjaro Christian Medical University College (Tanzania), Armauer Hansen Research Institute (Ethiopia), KNCV Tuberculosis Foundation (Netherlands), InVivo Biotech Services GmbH (Germany), and Aether Dynamics Consulting & Trading GmbH (Austria).
Project leader
Carol Joanne Church Holm-Hansen, Norwegian Institute of Public Health
Project participants
Aida Babaii, Researc Administrative Support, Norwegian Institute of Public Health
Ida Laake, Infection Control, Norwegian Institute of Public Health
Grant Theron, Stellenbosch University
Balthazar Nyombi, Kilimanjaro Christian Medical University College
Kidist Bobosha, AHRI Armauer Hansen Research Institute
Kristin Kremer, KNCV Tuberculosisfoundation
Nick Borain, Lateral Flow Laboratories (Pty) Ltd
Tim Welsink, InVivo Biotech Services GmbH
Aleksandar Josifoski, Aether Dynamics Consulting and Trading GmbH
Miloje Savic, Aether Dynamics Consulting and Trading GmbH
About the project
Start
01.01.2020
End
31.12.2025
Status
Active
Financing
European and Developing Countries Clinical Trials Partnership (EDCTP) grant code: RIA2018D-2493
Approvals
Regional committees for medical and health research ethics
Project owner/ Project manager
Norwegian Institute of Public Health
